Treatment of the colon cancer cells with piperlongumine resulted in downregulation of IDH1 in RKO (Figure 4A), SW480 (Figure 4B), and HCT116 (not significant) (Figure 4C) cells and selective downregulation of TXNDC5 in only SW480 cells. Here, IDH1 is linked to malignant colon neoplasm.